Nachrichten zur Whitehawk Therapeutics Inc. Aktie

HURA: Milestone Progression Over Next 12 Months

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn August 14th, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

HURA: Refining TBS-2025 Development Plan

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn May 15th, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

HURA: 2025 Financial Results

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn April 1st, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

Aadi Bioscience, Inc. (AADI) Expected to Beat Earnings Estimates: Should You Buy?

Aadi Bioscience (AADI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Arcadia Biosciences, Inc. (RKDA) Q3 2024 Earnings Call Transcript

…

Arcadia Biosciences, Inc. (RKDA) Q2 2024 Earnings Call Transcript

…

Aadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call Transcript

…

VENTYX NEWS NOTICE: Ventyx (Nasdaq: VTYX) Shareholders are Urged to Contact BFA Law about the Investigation into the Company’s Board of Directors

NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…

Spruce Biosciences und HMNC Brain Health kündigen strategische Zusammenarbeit zur Entwicklung einer Behandlung für Major Depressive Disorder (MDD) an

SOUTH SAN FRANCISCO, Kalifornien & MÜNCHEN--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB) („Spruce“), ein biopharmazeutisches Unternehmen im Spätstadium, das sich auf…

VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation

NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…

INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Directors of Ventyx Biosciences, Inc. for Potential Breaches of Fiduciary Duty

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…